Industry Odisha Bureau, Sep 22: The government is considering stronger medical device rules. Regulators could gain explicit powers to stop manufacture, sale and distribution of unsafe, defective or spurious products.*
The government is weighing changes to India’s medical device rules. The proposal targets Rule 30(1) of the Medical Devices Rules, 2017. Regulators could gain clearer powers over unsafe products. Authorities could stop manufacture, sale and distribution of affected devices.
Govt Seeks Clearer Medical Device Powers
The proposed amendment would strengthen enforcement under existing rules. It has reached the drugs consultative committee for deliberation. The committee comprises experts who will review the proposal. Both state licensing authorities and CDSCO could gain explicit powers. The Central Drugs Standard Control Organisation currently oversees national enforcement. These powers remain under consideration, not yet approved.
Unsafe Products Could Face Faster Action
The proposal covers devices described as unsafe or defective. Substandard and spurious products would also fall within scope. Regulators could direct licensees to halt production immediately. Sale and distribution could similarly be stopped. The measures target specific problematic products, not entire licences.
Existing Rules Focus on Licences
Current rules allow suspension or cancellation of licences. This applies when licensees violate the Drugs and Cosmetics Act, 1940. It also covers breaches of the Medical Devices Rules, 2017. However, these provisions centre on licence holders themselves. The proposed amendment would add product-specific enforcement powers. That marks a shift beyond licence-based regulatory action.
Regulators Could Order Product Destruction
The proposal envisages destruction of certain unsuitable devices. Affected stocks could also face supervised destruction. Regulatory oversight would accompany any disposal process. Documentation would likely support such procedures. Destruction would follow processes specified by regulators, not automatic penalties.
Patient Safety Drives Enforcement Debate
Medical devices span implants, surgical instruments and diagnostic equipment. Consumables also fall within this broad product category. These items feature routinely across critical healthcare settings. Defective or substandard products can present meaningful risks. Explicit powers could let regulators act more decisively. The proposal notes some devices may already breach statutory requirements.
Proposal Seeks Clearer Enforcement
Current Rule 30(1) lacks explicit provisions for these actions. That gap may create ambiguity around regulators’ available powers. It could also complicate consistent enforcement nationwide. The proposed amendment aims to close this gap. It would give authorities clearer tools against unsuitable products. Whether the committee approves the changes remains to be seen. The proposal nonetheless signals a move toward tighter product-level oversight.
